SUBSCRIBE
SUBSCRIBE

Dicerna Pharmaceuticals

NEWS
Dicerna Pharmaceuticals was acquired by Novo Nordisk in December 2021.
Future Leaders of the Next Generation of Business People
Business
A Flurry of Leadership Changes in Biotech
The past few days has had a flurry of activity in the industry with leadership changes. Let’s take a look at some of those!
September 26, 2018
 · 
3 min read
 · 
Alex Keown
Business
Moderna’s Vaccines Boss Leaves Company
Giuseppe Ciaramella, formerly chief scientific officer of Moderna Therapeutics’ Valera unit, has left for an unidentified stealth-mode biotech startup.
March 7, 2018
 · 
3 min read
 · 
Mark Terry
Business
Boehringer Focuses on RNA
Boehringer has made a big push into RNA this month.
November 27, 2017
 · 
1 min read
 · 
Karl Thiel
Dicerna Could Pocket $201M in NASH R&D Deal With B
Business
Dicerna Could Pocket $201M in NASH R&D Deal With Boehringer Ingelheim
Dicerna and Boehringer Ingelheim today announced a research collaboration and license agreement to discover and develop novel RNAi therapeutics for the treatment of chronic liver diseases.
November 2, 2017
 · 
4 min read
 · 
Alex Keown
Policy
Sparring Over Trade Secrets, Dicerna Brings New Antitrust Suit Against Alnylam
August 11, 2017
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Alnylam Slaps Dicerna With Trade Secret Lawsuit
June 11, 2015
 · 
4 min read
Job Trends
Booming Dicerna Takes a Larger Space in Cambridge and Plans to Hire
February 26, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Tekmira Announces $24.5M Licensing And Collaboration Agreement With Dicerna Pharmaceuticals
November 17, 2014
 · 
2 min read
Load More
IN THE PRESS
Deals
Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition
December 28, 2021
 · 
2 min read
Deals
Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna
December 25, 2021
 · 
8 min read
Deals
Novo Nordisk to Acquire Dicerna
November 18, 2021
 · 
12 min read
Business
Dicerna Announces Two Targets Meet Preclinical Proof of Principle Criteria in Neurodegeneration and Pain Under Global Research Collaboration and Licensing Agreement With Lilly
November 12, 2021
 · 
6 min read
Drug Development
Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021
November 12, 2021
 · 
12 min read
Business
Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update
November 9, 2021
 · 
14 min read
Genetown
Dicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data at American Society of Nephrology (ASN) Kidney Week 2021
November 4, 2021
 · 
12 min read
Business
Dicerna to Report Third Quarter 2021 Financial Results on Nov. 9, 2021
November 2, 2021
 · 
2 min read
Genetown
Dicerna Announces Results for PHYOX™4, Single-Dose Study of Nedosiran in Primary Hyperoxaluria Type 3 (PH3)
October 19, 2021
 · 
9 min read
Genetown
Dicerna Announces Data to Be Presented at American Society of Nephrology (ASN) Kidney Week 2021
October 15, 2021
 · 
7 min read
Load More